text: Secondary prevention measures include routine monitoring of laboratory values, including complete blood count (CBC) and metabolic panel.
option_0: Myeloproliferative neoplasm secondary prevention
option_1: Chronic myelogenous leukemia secondary prevention
option_2: Myelodysplastic syndrome primary prevention
option_3: Chronic myelogenous leukemia primary prevention
option_4: Aplastic anemia secondary prevention
option_5: Aplastic anemia primary prevention
option_6: Myeloproliferative neoplasm future or investigational therapies
option_7: Myeloproliferative neoplasm medical therapy